VFI in Healthy Vessels
Vector Flow Imaging in Healthy Vessels
1 other identifier
observational
20
1 country
1
Brief Summary
There is a wealth of evidence implicating the important role of blood flow throughout all stages of the process of atherogenesis. Two locations along the vascular tree at which atherosclerotic plaques are typically found are the carotid artery (CA) and the superficial femoral artery (SFA). Nowadays, ultrasound is the technique of choice for assessing the vascular condition in the CA and SFA. However, clinically used ultrasound techniques show a large variability in estimating the blood flow velocity, due to multiple limitations. With the advent of ultrafast ultrasound imaging, (almost) all elements of the transducer can be activated simultaneously. These so-called plane wave acquisition acquires thousands of images per second and makes continuous tracking of blood flow velocities in all directions in the field of view possible. This high-frame-rate acquisition opened up new possibilities for blood flow imaging at the CA and SFA, such as blood Speckle Tracking (bST) and ultrasound Particle Image Velocimetry (echoPIV). Both these vector flow imaging (VFI) techniques enable the quantification of 2D blood flow velocity profiles, where bST uses no contrast agents compared to echoPIV. Beside these novel ultrasound based techniques, 4D Phase Contrast Magnetic Resonance Imaging (4D flow MRI) enables a non-invasive quantification of the 4D blood flow velocity profiles (3D + time) and can be used as reference standard for blood flow assessments in-vivo. We therefore aim to evaluate the performance of both VFI techniques in comparison to 4D flow MRI measurements in the CA and SFA of healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Nov 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 6, 2022
CompletedFirst Posted
Study publicly available on registry
July 11, 2022
CompletedStudy Start
First participant enrolled
November 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
March 18, 2023
CompletedMay 6, 2023
May 1, 2023
4 months
July 6, 2022
May 5, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Validation VFI with MRI (echoPIV)
Two-dimensional vector velocity fields derived from VFI (echoPIV) and 4D flow MRI will be used to calculate the spatiotemporal blood flow velocity profiles in artery
1 day (no follow-up)
Validation VFI with MRI (bST)
Two-dimensional vector velocity fields derived from VFI (bST) and 4D flow MRI will be used to calculate the spatiotemporal blood flow velocity profiles in artery
1 day (no follow-up)
Secondary Outcomes (8)
Correlation VFI techniques (bST vs echoPIV)
1 day (no follow-up)
Flow derived parameters (WSS)
1 day (no follow-up)
Flow derived parameters (vorticity)
1 day (no follow-up)
Flow derived parameters (vector complexity)
1 day (no follow-up)
Old versus young (blood flow velocity profiles)
1 day (no follow-up)
- +3 more secondary outcomes
Study Arms (2)
Young volunteers
Volunteers with age between 20-30 years
Old volunteers
Volunteers with age between 65-75 years
Interventions
Blood speckle tracking measurements will be acquired of the carotid artery and superficial femoral artery
Ultrasound particle imaging velocimetry will be acquired of the carotid artery and superficial femoral artery
4D flow MRI will be acquired of the carotid artery and superficial femoral artery
Conventional duplex measurements will be acquired of the carotid artery and superficial femoral artery
Eligibility Criteria
The study population will include twenty healthy subjects divided in two different age groups. All volunteers will be recruited within Rijnstate hospital and Radboudumc.
You may qualify if:
- Healthy male or female, without cardiovascular and pulmonary medical history and without the use of medication for cardiovascular risk factors
- Age between 20-30 year or 65-75 years old
- Willingness to undergo a 4D flow MRI scan and US examinations
- Informed consent form understood and signed, and agrees to the hospital visit
You may not qualify if:
- Hypersensitivity to the active substance(s) or any of the excipients in Sonovue
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rijnstate Hospital
Arnhem, Gelderland, Netherlands
Related Publications (1)
Ruisch J, de Bakker JMK, van Helvert M, Schoonbrood MJP, Groot Jebbink E, Holewijn S, Reijnen MMPJ, de Korte CL, Saris AECM. Ultrasound-based Velocity Vector Imaging in the Carotid Bifurcation: Repeatability and an In Vivo Comparison With 4-D Flow MRI. Ultrasound Med Biol. 2025 Jun;51(6):969-976. doi: 10.1016/j.ultrasmedbio.2025.02.008. Epub 2025 Mar 6.
PMID: 40055083DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michel Reijnen, MD, Prof
Rijnstate Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2022
First Posted
July 11, 2022
Study Start
November 5, 2022
Primary Completion
March 18, 2023
Study Completion
March 18, 2023
Last Updated
May 6, 2023
Record last verified: 2023-05